A

AbbVie

Global biopharmaceutical company developing medicines

Director of Toxicology

Biology & BiotechConfirmed live in the last 24 hours
Full-timeShanghai, ChinaNo salary listed

About the Job

Requirements

  • A PhD, Doctor of Veterinary Medicine, or Doctor of Medicine is required.
  • At least 10 years of relevant experience in the pharmaceutical industry leading nonclinical safety programs.
  • Experience preparing relevant regulatory documents and responding to requests from regulatory agencies in China.
  • Experience in nonclinical toxicology study conduct, GLP knowledge and expectations, and associated practices.
  • Familiarity with global guidance, including China, the United States, and EMA requirements supporting nonclinical development.
  • Professional proficiency in Chinese and English, including spoken Mandarin and English fluency.
  • Strong timeline and project management skills.
  • Proficiency with standard computer applications, including Microsoft Word, Excel, and PowerPoint.
  • Ability to anticipate, recognize, and resolve scientific and technical problems encountered during drug development.
  • Ability to collaborate with other functional areas and within a matrix organization.

Responsibilities

  • Provide oversight of China-based CRO nonclinical toxicology studies and support nonclinical development programs and regulatory submissions in China.
  • Serve as the liaison between AbbVie and the China-based CRO, ensuring effective initiation, conduct, and completion of nonclinical toxicology studies performed in China.
  • Maintain ongoing communication with appropriate AbbVie U.S. stakeholders throughout the study lifecycle.
  • Prepare briefing books, CTDs, and responses to CDE inquiries, and provide regulatory guidance for intended interactions.
  • Work closely with the U.S.-based DBS development representative and/or study monitor to ensure alignment and consistency across program activities.
  • Prepare nonclinical documents to support clinical studies and regulatory submissions in China.
  • Respond to inquiries from the CDE and clinical sites to support ongoing clinical trials, as needed.
  • Monitor CRO-based nonclinical toxicology studies conducted in China.
  • Communicate nonclinical safety needs from a China perspective across drug modalities, including small molecules, biologics, ADCs, and cell and gene therapies, and across therapeutic areas including oncology, neuroscience, and immunology.
  • Author and submit regulatory documents, including IBs, INDs/CTAs, NDAs/BLAs, and regulatory responses, and interact with China regulatory agencies as needed.
  • Conduct China test-facility inspections, as needed, to ensure study quality and performance.
  • Manage relationships with vendors and key collaborators.
  • Rapidly resolve issues or conflicts associated with study conduct.

About the Company

AbbVie

Global biopharmaceutical company developing medicines

AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.

Company size
10,001+
Company stage
IPO
Headquarters
North Chicago, IL
Founded
1888

Recently Posted Jobs

Explore more opportunities at AbbVie

See more jobs